Further, the effects of modulating ABCA1 by CS-6253 on myelination were recently reported [92] and may shed light on other AD-relevant pathology including neuroinflammation, neuronal activity, and complementary behavioral assays. Here, ABCA1 is linked to Alzheimer disease.